Comparison of two ELISA methods for measuring levels of the phosphorylated neurofilament heavy chain

被引:53
作者
Petzold, Axel
Shaw, Gerry
机构
[1] UCL, Dept Neuroimmunol, Inst Neurol, London WC1N 3BG, England
[2] Univ Florida, Coll Med, Dept Neurosci, Evelyn F & William L McKnight Brain Inst, Gainesville, FL 32611 USA
关键词
neurofilament; NfH; NF-H; pNfH; biomarker;
D O I
10.1016/j.jim.2006.09.021
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Background: Recent studies suggest that the quantification of neurofilament subunits in cerebrospinal fluid (CSF), blood and amniotic fluid may reflect neuroaxonal damage and be of high clinical value. The present study aims to cross-validate two different independently developed ELISA techniques for the quantification of the phosphorylated axonal forms of the neurofilament heavy chain (pNfH). Methods: The London ELISA method is based on barbitone buffer and the commercially available SM135 capture antibody. The Gainesville method uses Tris-buffered saline (TBS) and an affinity purified chicken polyclonal capture antibody (C-pNfH). Coded CSF from 50 patients with neurological diseases were analyzed in duplicate by both laboratories, each using both ELISA methods, but with each lab using their own detection antibody, tertiary antibody and chromogen. Methods were compared using Bland Altman plots. Correlation and regression analyses were used to allow for transformation of values between both methods. Results: The Bland-Altman plots demonstrated that 96% of all samples fell into the narrow 95% limits of agreement (0.04 units of OD). There was a high correlation (Spearman R = 0.92, p < 0.0001 and Pearson R = 0.98, p < 0.0001) between the Gainesville (1) and the London (X) method with Y=0.132+1.104*X. The previously determined upper reference limit of 0.73 mg/l (London method) corresponds to 0.94 mg/l for the Gainesville method. CSF pNfH levels above the reference limit were observed in patients with encephalitis, encephalomyelitis, hydrocephalus, subarachnoid haemorrhage, spino-muscular atrophy, stroke and cancer with both methods agreeing in all cases. Conclusion: The two assays are in excellent agreement, suggesting that pNfH, which has a number of unusual protein chemical features, may be the biomarker of choice for the routine and robust detection of axonal injury and degeneration in both research and clinical contexts. (c) 2006 Elsevier B.V. All rights reserved.
引用
收藏
页码:34 / 40
页数:7
相关论文
共 8 条
[1]   Measuring agreement in method comparison studies [J].
Bland, JM ;
Altman, DG .
STATISTICAL METHODS IN MEDICAL RESEARCH, 1999, 8 (02) :135-160
[2]  
Burtis C.A., 1994, Tietz Textbook of Clinical Chemistry
[3]   Neurofilament phosphoforms: Surrogate markers for axonal injury, degeneration and loss [J].
Petzold, A .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2005, 233 (1-2) :183-198
[4]   A specific ELISA for measuring neurofilament heavy chain phosphoforms [J].
Petzold, A ;
Keir, G ;
Green, AJE ;
Giovannoni, G ;
Thompson, EJ .
JOURNAL OF IMMUNOLOGICAL METHODS, 2003, 278 (1-2) :179-190
[5]  
Shaw, 1998, NEUROFILAMENTS
[6]   Hyperphosphorylated neurofilament NF-H is a serum biomarker of axonal injury [J].
Shaw, G ;
Yang, C ;
Ellis, R ;
Anderson, K ;
Mickle, JP ;
Scheff, S ;
Pike, B ;
Anderson, DK ;
Howland, DR .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 336 (04) :1268-1277
[7]   Biological markers in CSF and blood for axonal degeneration in multiple sclerosis [J].
Teunissen, CE ;
Dijkstra, C ;
Polman, C .
LANCET NEUROLOGY, 2005, 4 (01) :32-41
[8]   An enzyme immunoassay to quantify neurofilament light chain in cerebrospinal fluid [J].
Van Geel, WJA ;
Rosengren, LE ;
Verbeek, MM .
JOURNAL OF IMMUNOLOGICAL METHODS, 2005, 296 (1-2) :179-185